A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Istituto Oncologico Veneto IRCCS
AstraZeneca
Essen Biotech
Essen Biotech
University of Nebraska
Conjupro Biotherapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Natera, Inc.
Second Life Therapeutics
Elephas
Elephas
University Health Network, Toronto
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Delfi Diagnostics Inc.
Milton S. Hershey Medical Center
Columbia University
Tempus AI